LiveCare, Inc. (LVCE)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
LiveCare, Inc. (LVCE) with AI Score 46/100 (Weak). LiveCare, Inc. is a health information services company focused on providing solutions for individuals with type II diabetes and other chronic diseases. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026LiveCare, Inc. (LVCE) Healthcare & Pipeline Overview
LiveCare, Inc. addresses the diabetic epidemic with technology-driven solutions and personalized care. As a real-time health, analytics, service, and monitoring company, LiveCare focuses on individuals with type II diabetes. Based in Venice, Florida, LiveCare operates in the health information services sector, emphasizing a human-touch approach.
Investment Thesis
LiveCare, Inc. presents a unique opportunity within the health information services sector, targeting the growing diabetic epidemic. The company's focus on real-time health analytics and personalized solutions for type II diabetes could drive adoption and revenue growth. However, with a negative profit margin of -288.3% and a negative gross margin of -229.1%, the company needs to demonstrate a clear path to profitability. The high beta of 1.66 indicates significant volatility. Key catalysts include expanding service offerings and partnerships with healthcare providers. Investors should closely monitor the company's ability to improve financial performance and manage operational costs.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates the company is in its early stages of growth.
- Profit margin of -288.3% reflects significant operational challenges and the need for improved cost management.
- Gross margin of -229.1% suggests the company is selling its services at a loss, requiring a reevaluation of pricing strategies.
- Free cash flow of $-0.00B indicates the company is not generating positive cash flow, potentially requiring external funding.
- Beta of 1.66 suggests the stock is more volatile than the market, posing higher risk for investors.
Strengths
- Focus on a specific niche market (type II diabetes).
- Technology-driven platform for real-time health monitoring.
- Personalized care approach.
- Potential for partnerships with healthcare providers.
Weaknesses
- Negative profit and gross margins.
- Limited market capitalization.
- High beta indicating significant volatility.
- Dependence on external funding.
Catalysts
- Upcoming: Potential partnerships with healthcare providers to expand market reach.
- Ongoing: Continued development and enhancement of the technology platform.
- Ongoing: Increasing adoption of remote patient monitoring solutions due to the COVID-19 pandemic.
- Upcoming: Expansion of service offerings to include additional chronic diseases.
- Upcoming: Positive results from clinical trials or studies demonstrating the effectiveness of LiveCare's solutions.
Risks
- Potential: Competition from established health tech companies.
- Potential: Regulatory changes affecting the health information services industry.
- Ongoing: Negative profit and gross margins indicating financial instability.
- Potential: Dependence on external funding to sustain operations.
- Potential: Data breaches and privacy concerns affecting patient trust.
Growth Opportunities
- Expanding service offerings to include additional chronic diseases beyond diabetes presents a significant growth opportunity. The market for chronic disease management is substantial, with increasing demand for remote monitoring and personalized care solutions. By diversifying its services, LiveCare can tap into new revenue streams and broaden its customer base. This expansion could be achieved through strategic partnerships, acquisitions, or internal development, with a potential timeline of 2-3 years.
- Strategic partnerships with healthcare providers and insurance companies can drive adoption of LiveCare's solutions. Collaborating with established players in the healthcare ecosystem can provide access to a wider patient base and streamline the integration of LiveCare's services into existing workflows. These partnerships can also enhance the credibility and market visibility of LiveCare, fostering trust among patients and providers. The timeline for establishing such partnerships is estimated at 1-2 years.
- Leveraging data analytics to improve patient outcomes and reduce healthcare costs can create a competitive advantage for LiveCare. By analyzing real-time health data, the company can identify patterns, predict potential health issues, and personalize interventions to optimize patient care. This data-driven approach can also demonstrate the value of LiveCare's solutions to healthcare providers and insurance companies, driving adoption and revenue growth. The timeline for fully implementing and leveraging advanced data analytics is approximately 1-2 years.
- Geographic expansion into new markets can fuel growth for LiveCare. The demand for remote patient monitoring and chronic disease management solutions is global, presenting opportunities to expand beyond the company's current base in Florida. Entering new markets may require adapting the company's services to local regulations and cultural preferences. This expansion could be achieved through strategic partnerships, acquisitions, or establishing a local presence, with a potential timeline of 2-3 years.
- Developing and integrating wearable technology into LiveCare's platform can enhance the user experience and improve data collection. Wearable devices can provide continuous monitoring of vital signs and activity levels, enabling more personalized and timely interventions. Integrating this technology into LiveCare's ecosystem can differentiate the company from competitors and attract tech-savvy patients. The timeline for developing and integrating wearable technology is estimated at 1-2 years.
Opportunities
- Expanding service offerings to include other chronic diseases.
- Geographic expansion into new markets.
- Integrating wearable technology into the platform.
- Leveraging data analytics to improve patient outcomes.
Threats
- Competition from established health tech companies.
- Regulatory changes and technological advancements.
- Economic downturn affecting healthcare spending.
- Potential for data breaches and privacy concerns.
Competitive Advantages
- Proprietary technology platform for real-time health monitoring and data analytics.
- Personalized care approach that fosters patient engagement and adherence.
- Strategic partnerships with healthcare providers and insurance companies.
- Focus on a specific niche market (type II diabetes) allows for specialized expertise.
About LVCE
LiveCare, Inc., incorporated in 2018 and based in Venice, Florida, is dedicated to combating the diabetic epidemic and other chronic diseases. The company operates as a real-time health, analytics, service, and monitoring provider, delivering solutions tailored for individuals managing type II diabetes. LiveCare combines state-of-the-art technologies with a human-centered approach to enhance patient care and outcomes. LiveCare's core focus is on providing comprehensive support through real-time data analysis and personalized interventions. The company's solutions are designed to empower patients to better manage their conditions and improve their overall quality of life. By integrating technology with compassionate care, LiveCare aims to bridge the gap between healthcare providers and patients, fostering a collaborative environment for effective disease management. The company's commitment to innovation and patient-centric care positions it as a key player in the evolving landscape of health information services.
What They Do
- Provides real-time health monitoring for individuals with type II diabetes.
- Offers data analytics services to track and manage chronic diseases.
- Delivers personalized solutions for diabetes management.
- Combines technology with a human-touch approach to patient care.
- Focuses on improving patient outcomes through proactive interventions.
- Aims to reduce healthcare costs by preventing complications.
Business Model
- Generates revenue through subscriptions to its health monitoring and analytics platform.
- Partners with healthcare providers and insurance companies to offer its services to patients.
- Provides personalized care plans and support services for individuals with diabetes.
Industry Context
LiveCare, Inc. operates within the health information services industry, which is experiencing rapid growth due to the increasing prevalence of chronic diseases like diabetes. The market is driven by the need for remote patient monitoring, data analytics, and personalized care solutions. Competitors include established health tech companies and emerging startups. LiveCare's success depends on its ability to differentiate itself through innovative technology and effective patient engagement strategies. The industry is subject to regulatory changes and technological advancements, requiring companies to adapt quickly to maintain a competitive edge.
Key Customers
- Individuals with type II diabetes seeking to manage their condition.
- Healthcare providers looking to improve patient outcomes and reduce costs.
- Insurance companies aiming to lower healthcare expenses through proactive disease management.
Financials
Chart & Info
LiveCare, Inc. (LVCE) stock price: Price data unavailable
Latest News
No recent news available for LVCE.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LVCE.
Price Targets
Wall Street price target analysis for LVCE.
MoonshotScore
What does this score mean?
The MoonshotScore rates LVCE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Health Information ServicesLVCE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that LiveCare, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures and transparency.
- Potential for fraud and market manipulation.
- Low trading volume and liquidity.
- Higher price volatility.
- Lack of regulatory oversight.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal standing.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Verify the company's registration and licensing.
- Check for independent audits of financial statements.
- Assess the company's website and online presence.
- Look for positive news coverage and industry recognition.
- Evaluate the company's investor relations and communication practices.
LVCE Healthcare Stock FAQ
What does LiveCare, Inc. do?
LiveCare, Inc. is a health information services company that focuses on providing solutions for individuals with type II diabetes and other chronic diseases. The company utilizes state-of-the-art technologies and a human-touch approach to deliver real-time health analytics, services, and monitoring. LiveCare's platform aims to empower patients to better manage their conditions, improve their overall quality of life, and reduce healthcare costs by preventing complications. The company partners with healthcare providers and insurance companies to offer its services to a wider patient base.
What do analysts say about LVCE stock?
As of 2026-03-16, formal analyst coverage of LiveCare, Inc. (LVCE) is limited, likely due to its OTC listing and small market capitalization. Key valuation metrics such as price-to-earnings ratio are not meaningful given the company's current negative profitability. Growth considerations center on the company's ability to expand its service offerings, secure strategic partnerships, and improve its financial performance. Investors should conduct thorough due diligence and assess the company's long-term potential in the context of its inherent risks and challenges.
What are the main risks for LVCE?
LiveCare, Inc. faces several key risks, including intense competition from established health tech companies, regulatory changes affecting the health information services industry, and the company's current negative profit and gross margins, which indicate financial instability. The company's dependence on external funding to sustain operations also poses a risk, as does the potential for data breaches and privacy concerns that could affect patient trust. Investors should carefully consider these risks before investing in LVCE.
What are the key factors to evaluate for LVCE?
LiveCare, Inc. (LVCE) currently holds an AI score of 46/100, indicating low score. Key strength: Focus on a specific niche market (type II diabetes).. Primary risk to monitor: Potential: Competition from established health tech companies.. This is not financial advice.
How frequently does LVCE data refresh on this page?
LVCE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven LVCE's recent stock price performance?
Recent price movement in LiveCare, Inc. (LVCE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on a specific niche market (type II diabetes).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider LVCE overvalued or undervalued right now?
Determining whether LiveCare, Inc. (LVCE) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying LVCE?
Before investing in LiveCare, Inc. (LVCE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be limited and less reliable than major exchange data.